“…FDA approved telepathology systems, used for screening, primary diagnosis, second opinion, and education, can be designed as a static mode (images are captured, transmitted, and then viewed at distance), dynamic mode (live video images are transmitted and viewed at distance in real time), or dynamic robotic mode (when the viewer controls the microscope at the originating site) [17,18]. The practice of telepathology has been validated in surgical pathology (frozen section) and cytology [19,20 ▪▪ ,21–23], however, in renal pathology it is currently under testing. The two major indications that best fit the use of telepathology are assessment of adequacy of tissue procurement at the time of the renal biopsy (currently under validation at the University of Miami), and adequacy of renal parenchyma from frozen sections prior to transplantation.…”